Related Experiment Videos
Risk factors for incident nuclear opacities
M Cristina Leske1, Suh-Yuh Wu, Barbara Nemesure
1School of Medicine, Department of Preventive Medicine, Stony Brook University Medical Center, HSC L-3 RM 086, Stony Brook, NY 11794-8036, USA.
Ophthalmology
|July 3, 2002
Summary
This study identified key risk factors for nuclear opacities, including age, female gender, darker iris color, myopia, diabetes, and lower body mass. Topical intraocular pressure-lowering medications significantly increased nuclear opacity risk.
Area of Science:
- Ophthalmology
- Epidemiology
Background:
- Nuclear opacities are a leading cause of visual impairment globally.
- Understanding risk factors is crucial for developing preventative strategies.
Purpose of the Study:
- To identify risk factors associated with the 4-year incidence of nuclear opacities in a population-based cohort.
- To investigate the role of intraocular pressure (IOP)-lowering medications in nuclear opacity development.
Main Methods:
- A 4-year prospective, population-based cohort study of 2609 Black participants in the Barbados Eye Studies.
- Ophthalmic examinations, interviews, and standardized measurements were conducted at baseline and follow-up.
- Logistic regression analysis was used to evaluate risk factors for nuclear opacities.
Main Results:
- The 4-year incidence of nuclear opacities was 9.2%.
- Risk factors included older age, female gender, darker iris color, myopia, diabetes, and lower body mass index.
- Topical intraocular pressure (IOP)-lowering medications were associated with a threefold increased risk of nuclear opacities.
Conclusions:
- Age, female gender, darker iris color, myopia, diabetes, and leaner body mass are significant risk factors for nuclear opacities.
- The use of topical IOP-lowering medications demonstrated a strong association with increased nuclear opacity risk, warranting further investigation.
- Findings highlight potential targets for interventions to reduce the incidence of nuclear opacities.